Rights and permissions
About this article
Cite this article
Risk-based GBS prevention strategy valuable to HMOs. Pharmacoecon. Outcomes News 213, 7 (1999). https://doi.org/10.1007/BF03290024
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03290024